[print]   [close]
SANIONA
BIOTECHGATE BY VENTURE VALUATION
Latest up-date: 13 May 2019
GENERAL INFORMATION
 
Baltorpvej 154
2750 Ballerup
Denmark
Contact person Dr. Jørgen Drejer, CEO and founder
Company main phone +45 (70) 705225
Website www.saniona.com
Founded (year) 2011
Source of foundation Independent foundation
   
Corporate description / mission
Saniona is a research and development company focused on drugs for diseases of the central nervous system and eating disorders. The company has five programs in clinical development. Saniona intends to develop and commercialize treatments for orphan indications such as Prader-Willi syndrome and hypothalamic obesity on its own. The research is focused on ion channels and the company has a broad portfolio of research programs.
State of ownership Publicly listed on stock exchange
Headquarters Yes
IPO (year) 2014
CATEGORIZATION  
Main sector Biotechnology - Therapeutics and Diagnostics
Subsector(s)
  • Other
  • Small molecules
Primary therapeutic area(s)
  • Diseases of the blood and blood-forming organs; immune disorders
  • Endocrine, nutritional and metabolic diseases
  • Mental and behavioural disorders
  • Diseases of the nervous system
  • Digestive system
  • Musculoskeletal system and connective tissue
  • Genitourinary system
 
Business model
  • R&D
Customer segments
  • Large biotech & big pharma
  • Small biotech
  • Physicians / doctors
  • Hospitals
SUMMARY PRODUCTS / SERVICES / TECHNOLOGIES  
No. of Biotech Products Pre-clinical Phase I Phase II Phase III On the market
  2 1 5 1 n/a
Description of products
Tesofensine
Tesomet - T2D
Tesomet - PWS
NS2359
CAD-1883
SAN711
Technology used
Ion channel programs and technologies:
GABA modulators
K+ modulators
Nicotinic modulators
FINANCING DETAILS
Fiscal year (end of) 2018
Revenues DKK 54.88M
Cash DKK 54.68M
Market capitalization / valuation DKK 590.11M
Money raised to date
(at least)		 SEK 269.40M
 
Primary stock exchange OMX Stockholm Stock Exchange (SANION.ST)
Financing details
Market cap as on 13 May 19
COLLABORATIONS, CLIENTS & MARKETS  
Partnering strategy / collaborations
Boehringer Ingelheim
Cadent Therapeutics
Productos Medix
The Michael J. Fox Foundation
TRC, University of Pennsylvania.

 
ASK OUR LIFE SCIENCE EXPERT IN THE DANISH MARKET
Did you find what you were looking for? If not, feel free to contact us. We have in-depth knowledge of the biotech- and pharma industry, company pipelines and partnering opportunities in Medicon Valley.
 
Get in touch:
All fields are required.

Consultant: Niels Thun Andersen
Name:
Company:
E-Mail Address:
Subject:
Message:
CAPTCHA code

Please enter the above code into the field below.


 
 
© 2019 Venture Valuation  |  Impressum  |  Terms of Use & Privacy Policy  |  Print